GenPAx
Nigel Saunders is the CSO at Genpax. Nigel is an expert in clinical bacteriology and genomics. Most recently Interdisciplinary (Bioscience, Computer Science, & Maths) Professor of Systems Biology at Brunel University London, he was formerly head of the Bacterial Pathogenesis and Functional Genomics Group, at the Dunn School of Pathology, and Wellcome Fellow in Medical Microbiology at the Institute of Molecular Medicine, Oxford University. At Oxford, he was also a Founding Manager of the Computational Biology Research Group.
Notable achievements include changing the use/monitoring of vancomycin antibiotics, contributions to the sequencing project underpinning the BEXSERO vaccine, and pioneering work in microarray comparative and functional genomics.
This person is not in any offices
GenPAx
1 followers
GenPAx is a biotechnology company enabling next-generation precision medicine to fight pathogens. GenPAx will provide fast, high definition, affordable data analysis of bacteria genome sequence data globally. GenPAx aims to provide clinics, laboratories, and hospitals with vital infection control information in order to derive solutions to contain, treat and eradicate threats to mankind.